Testosterone replacement in menopause – BMS Toolkit for Clinicians

Categories:

The British Menopause Society has this month released a Tools for Clinicals publication entitled Testosterone replacement in menopause.

Authored by Mr Nick Panay, Consultant Gynaecologist, Imperial College Healthcare & Chelsea and Westminster Hospitals, London; Trustee and Past Chairman – British Menopause Society; General Secretary, International Menopause Society and former Editor-in Chief Climacteric, The Journal of the IMS, in collaboration with the medical advisory council of the British Menopause Society this clearly written and concise summary reflects the latest in clinical use recommendations for clinicians in day-to-day practice.

Available online the document provides guidance on:

  • Physiology
  • Role of T in women
  • Impact of T deficiency
  • Other effects of T  in post menopausal women
  • FADS / HSDD / FSIAD
  • T assays – measurement and  interpretation of results
  • Indications for T use in women
  • UK available options
  • How to and response management
  • Potential adverse effects
  • When to avoid and cautions
  • Suggested reading

 

To view see https://thebms.org.uk/publications/tools-for-clinicians/testosterone-replacement-in-menopause/ 

 

Latest News


AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women

Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →

The Menopause Charity launches in the UK The Menopause Charity launches in the UK

Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →

Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1 Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1

Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →